EDUCATION

Graduate Degree

  • Washington University of St. Louis , St. Louis , MO

Medical School

  • Washington University of St. Louis , St. Louis , MO

Internship

  • Boston Children's Hospital , Boston , MA

Residency

  • Boston Children's Hospital , Boston , MA

Fellowship

  • Boston Children's Hospital , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Rheumatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI Insight. 2021 Sep 22; 6(18). View abstract
  2. Uveitis in Children and Adolescents. Rheum Dis Clin North Am. 2021 Nov; 47(4):619-641. View abstract
  3. New-onset Hypogammaglobulinemia and Infectious Complications Associated with Rituximab Use in Childhood-onset Rheumatic Diseases. Rheumatology (Oxford). 2021 Jul 30. View abstract
  4. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol. 2021 09; 148(3):732-738.e1. View abstract
  5. Childhood Sjögren syndrome: features of an international cohort and application of the 2016 ACR/EULAR classification criteria. Rheumatology (Oxford). 2021 07 01; 60(7):3144-3155. View abstract
  6. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2. Arthritis Rheumatol. 2021 08; 73(8):e46-e59. View abstract
  7. Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children. J Clin Rheumatol. 2021 Mar 16. View abstract
  8. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3. View abstract
  9. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View abstract
  10. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020 11; 72(11):1809-1819. View abstract
  11. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight. 2020 03 26; 5(6). View abstract
  12. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol. 2020 05; 214:108385. View abstract
  13. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020 02; 79(2):225-231. View abstract
  14. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319. View abstract
  15. Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis. Arthritis Care Res (Hoboken). 2019 04; 71(4):482-491. View abstract
  16. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019 Feb 14; 17(1):7. View abstract
  17. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus. Front Immunol. 2018; 9:1278. View abstract
  18. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy. Curr Opin Rheumatol. 2018 03; 30(2):222-228. View abstract
  19. Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis. 2018 Jan; 21(1):64-69. View abstract
  20. Adolescent and parent perspectives on medical decision-making for chronic illness. Fam Syst Health. 2018 06; 36(2):248-251. View abstract
  21. Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) gene. J Autoimmun. 2018 01; 86:116-119. View abstract
  22. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. J Am Heart Assoc. 2017 May 31; 6(6). View abstract
  23. Monogenic Lupus. Curr Rheumatol Rep. 2016 Dec; 18(12):71. View abstract
  24. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016 11 22; 12(12):716-730. View abstract
  25. Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2016 07; 68(7):1758-68. View abstract
  26. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J. 2016 Feb 16; 14(1):9. View abstract
  27. Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. J Allergy Clin Immunol. 2015 Jan; 135(1):272-3. View abstract
  28. A70: medication use in the treatment of juvenile idiopathic uveitis patients enrolled in the childhood arthritis and rheumatology research alliance registry. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S102. View abstract
  29. A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S156. View abstract
  30. A181: evaluating decision-making in a pediatric rheumatology clinic. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S237. View abstract
  31. Outcomes in hospitalized pediatric patients with systemic lupus erythematosus. Pediatrics. 2014 Jan; 133(1):e106-13. View abstract
  32. Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. Pediatr Rheumatol Online J. 2013 Nov 01; 11(1):42. View abstract
  33. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant. 2013 Mar; 17(2):133-43. View abstract
  34. cAMP response element modulator a controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci U S A. 2012 Oct 09; 109(41):16606-11. View abstract
  35. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Ann N Y Acad Sci. 2012 Jan; 1247:138-52. View abstract
  36. Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus. Methods Mol Biol. 2012; 900:25-60. View abstract
  37. Sublingual desensitization for buprenorphine hypersensitivity. J Allergy Clin Immunol. 2010 Apr; 125(4):938-9. View abstract
  38. Respiratory viral infections in immunocompromised children. Pediatric Academic Societies. 2009. View abstract
  39. Improved IFN efficacy and viral clearance by engineering a Super-Stat1 transgene. American Thoracic Society. 2007. View abstract
  40. Anorexia Nervosa. Underground Clinical Vignettes: Pediatrics (edited by Kim S, Swanson T and Wasserman JD). 2007. View abstract
  41. Varicella Zoster. Underground Clinical Vignettes: Pediatrics (edited by Kim S, Swanson T and Wasserman JD). 2007. View abstract
  42. Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J Biol Chem. 2005 Oct 07; 280(40):34306-15. View abstract
  43. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol. 2005 Jul; 79(14):9315-9. View abstract
  44. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 2(2):132-40. View abstract
  45. Defining and adjusting divergent host responses to viral infection. Immunol Res. 2005; 32(1-3):123-41. View abstract
  46. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev. 2002 Jan; 82(1):19-46. View abstract
  47. Role of Stat1 in defense against respiratory viruses. Proceedings of Keystone Symposium: Molecular Aspects of Viral Immunity. 2001; 56. View abstract
  48. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach. Blood. 1999 Nov 01; 94(9):3027-36. View abstract